Skip to main content
. 2018 Nov 9;97(45):e13120. doi: 10.1097/MD.0000000000013120

Figure 1.

Figure 1

Study design. Day 0 = pre-vaccination; HIV+ART+ = HIV-positive participants on antiretroviral therapy; HIV+ART- = HIV-positive, antiretroviral therapy-naïve participants; HIV− = HIV-negative participants; only for HIV+ cohorts; ∗∗only for HIV+ART- cohort.